BiologicsMD
1 known investors
BiologicsMD develops recombinant fusion proteins targeting parathyroid hormone receptors for hair loss, bone disorders, and oncology treatments. The company's technology uses a dual-domain approach to localize therapeutics to disease sites with minimal off-target effects.
BiotechDeep TechMedical Devices
Investors · 1
In the news
- BiologicsMD - 2026 Company Profile, Team, Funding & Competitors - Tracxntracxn.com · 2021
- Patented Protein from Fayetteville Firm Treats Bone and Hair Lossarkansasbusiness.com · 2015
- BiologicsMD, Inc. Awards Manufacturing Contract to Cytovance Biologics, Inc. to Expand Development of Breakthrough Osteoporosis Medication | Business Wirebusinesswire.com · 2012
- BiologicsMD of Fayetteville Gets $2.3 Million Contractarkansasbusiness.com · 2011